Glycan-interacting Compounds And Methods Of Use

Abstract

The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives, and fragments thereof as well as compositions and kits comprising them. Further provided are methods of using glycan-interacting antibodies to target cells and treat disease.


Claims
CPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jan 30, 2018
  • Application: Jan 4, 2016
    US US 201614987432 A
  • Priority: Jan 4, 2016
    US US 201614987432 A
  • Priority: Nov 12, 2015
    US US 2015/0060287 W
  • Priority: Jul 1, 2015
    US US 201562187587 P
  • Priority: Jun 10, 2015
    US US 201562173560 P
  • Priority: Apr 9, 2015
    US US 201562145214 P
  • Priority: Jan 12, 2015
    US US 201562102527 P
  • Priority: Nov 12, 2014
    US US 201462078610 P

Download Citation


Sign in to the Lens

Feedback